LEADER 03903nam  22006975  450 
001 9910438004403321
005 20200701042359.0
010   $a1-283-69708-4
010   $a1-4614-3710-5
024 7 $a10.1007/978-1-4614-3710-9
035   $a(CKB)2670000000277555
035   $a(EBL)973511
035   $a(OCoLC)813298574
035   $a(SSID)ssj0000766958
035   $a(PQKBManifestationID)11445960
035   $a(PQKBTitleCode)TC0000766958
035   $a(PQKBWorkID)10731602
035   $a(PQKB)10921785
035   $a(DE-He213)978-1-4614-3710-9
035   $a(MiAaPQ)EBC973511
035   $a(PPN)16829818X
035   $a(EXLCZ)992670000000277555
100   $a20121009d2013      u|         0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 10$aChemotherapy in Psychiatry $ePharmacologic Basis of Treatments for Major Mental Illness /$fby Ross J. Baldessarini
205   $a3rd ed. 2013.
210  1$aNew York, NY :$cSpringer New York :$cImprint: Springer,$d2013.
215   $a1 online resource (278 p.)
300   $aDescription based upon print version of record.
311   $a1-4614-7926-6 
311   $a1-4614-3709-1 
320   $aIncludes bibliographical references and index.
327   $aModern Psychopharmacology and Psychiatric Treatment -- Antipsychotic Agents.- Antimanic and Mood-stabilizing Agents -- Antidepressant Agents -- Antianxiety Agents -- Status and Prospects for Psychopharmacology.Bibliography -- Index.                                                                                                                 .
330   $aExtensively updated since its second edition in 1985, Chemotherapy in Psychiatry, Third Edition, again addresses basic aspects of modern psychopharmacology and clinical applications of drugs used in the treatment of major psychiatric disorders, with major emphasis on psychotic, bipolar, and depressive disorders. The presentation covers descriptions of the main classes of psychotropic drugs, selected information concerning their known action mechanisms and metabolic disposition, and their clinical applications for acute illnesses and to prevent recurrences and long-term morbidity. Also covered are limitations and adverse effects of each type of agent, with emphasis on the fact that all psychotropic medicines have adverse effects that range from annoying to potentially lethal. Chemotherapy in Psychiatry, Third Edition, outlines the need to balance benefits and risks at the level of individual persons. Authoritative, and an important contribution to the literature, Chemotherapy in Psychiatry, Third Edition is an invaluable resource for physicians, scientists, trainees, and policymakers.
606   $aNeurology 
606   $aPsychiatry
606   $aInternal medicine
606   $aNeurosciences
606   $aNeurology$3https://scigraph.springernature.com/ontologies/product-market-codes/H36001
606   $aPsychiatry$3https://scigraph.springernature.com/ontologies/product-market-codes/H53003
606   $aInternal Medicine$3https://scigraph.springernature.com/ontologies/product-market-codes/H33002
606   $aNeurosciences$3https://scigraph.springernature.com/ontologies/product-market-codes/B18006
615  0$aNeurology .
615  0$aPsychiatry.
615  0$aInternal medicine.
615  0$aNeurosciences.
615 14$aNeurology.
615 24$aPsychiatry.
615 24$aInternal Medicine.
615 24$aNeurosciences.
676   $a616.89
676   $a616.8918
700   $aBaldessarini$b Ross J$4aut$4http://id.loc.gov/vocabulary/relators/aut$096333
906   $aBOOK
912   $a9910438004403321
996   $aChemotherapy in Psychiatry$92169318
997   $aUNINA